Skip to Main Content (Press Enter)

Logo UNISR
  • ×
  • Home
  • Persone
  • Pubblicazioni
  • Facoltà
  • Ambiti Di Ricerca

UNIFIND
Logo UNISR

|

UNIFIND

unisr.it
  • ×
  • Home
  • Persone
  • Pubblicazioni
  • Facoltà
  • Ambiti Di Ricerca
  1. Pubblicazioni

Menstruation-Related Disorders-Dysmenorrhea and Heavy Bleeding-as Significant Epiphenomena in Women With Rheumatic Diseases

Articolo
Data di Pubblicazione:
2022
Citazione:
Menstruation-Related Disorders-Dysmenorrhea and Heavy Bleeding-as Significant Epiphenomena in Women With Rheumatic Diseases / Orlandi, Martina; Vannuccini, Silvia; El Aoufy, Khadija; Melis, Maria Ramona; Lepri, Gemma; Sambataro, Gianluca; Bellando-Randone, Silvia; Guiducci, Serena; Cerinic, Marco Matucci; Petraglia, Felice. - In: FRONTIERS IN PHARMACOLOGY. - ISSN 1663-9812. - 13:(2022). [10.3389/fphar.2022.807880]
Abstract:
: Background: In women with rheumatic diseases (RDs) menstruation-related disorders have never been investigated. The aim of this study was to evaluate gynecological symptoms/disorders in fertile age women with RDs. Materials and methods: All patients (n = 200) filled up a self-administered questionnaire on their gynecological history, menstrual cycle pattern, menstrual-related symptoms, and quality of life (QoL). The RD group was then compared to a control group of 305 age-matched fertile age women. Results: Among patients with RDs, 58% had arthritis, 40% connective tissue diseases (CTDs), and 1.5% systemic vasculitis. No differences were observed between CTDs and arthritis, except for a family history of HMB which was more common among women with CTDs (p < .01). When compared to controls, women with RDs reported more frequent heavy menstrual bleeding (HMB) during adolescence (51.7 and 25.4%, respectively; p = .0001) and adult life (37.7 and 25.9%, respectively; p = .0065). Also, dysmenorrhea in adolescence was significantly more common among cases (55.6 and 45.4%, respectively; p = .0338). Gynecological pain (dysmenorrhea, non-menstrual pelvic pain, dyspareunia, dysuria, and dyschezia) in patients with RDs was more frequent than in controls (p = .0001, .0001, .0001, .0001, .0002, respectively). Considering women who reported moderate and severe symptoms in RDs, dysmenorrhea and dyspareunia remain significantly more frequent in women with RDs than in controls (p = .0001; p = .0022; respectively). QoL scores were significantly reduced in women with RDs, either in physical (p = .0001) and mental domains (p = .0014) of short-form 12. Conclusion: Women affected by RDs frequently presented menstruation-related disorders; thus, female patients with RDs should be questioned about gynecological symptoms and referred to the gynecologist for an accurate evaluation.
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Orlandi, Martina; Vannuccini, Silvia; El Aoufy, Khadija; Melis, Maria Ramona; Lepri, Gemma; Sambataro, Gianluca; Bellando-Randone, Silvia; Guiducci, Serena; Cerinic, Marco Matucci; Petraglia, Felice
Autori di Ateneo:
MATUCCI CERINIC MARCO
Link alla scheda completa:
https://iris.unisr.it/handle/20.500.11768/154414
Link al Full Text:
https://iris.unisr.it//retrieve/handle/20.500.11768/154414/190807/fphar-13-807880.pdf
Pubblicato in:
FRONTIERS IN PHARMACOLOGY
Journal
  • Dati Generali

Dati Generali

URL

https://www.frontiersin.org/articles/10.3389/fphar.2022.807880/full
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.0.0